Vesalius Innovation Award Joins Forces with BMJ Group to Propel Startups in Science Communication

Basel, Switzerland — A notable advancement in the field of scientific communication, the Vesalius Innovation Award heralds a new era of collaboration and ingenuity as it enters its fifth year, this time with BMJ Group partnering alongside Karger Publishers as co-presenters. The award aims to catalyze progress in the dissemination and effectiveness of scientific knowledge, offering a hefty total of $25,000 in prize money to the most innovative contenders in the industry.

This pioneering award seeks to honor groundbreaking approaches in science communication, covering a wide array of crucial elements including artificial intelligence, research integrity, and educational methodologies, as well as new business frameworks in the publishing domain. It emphasizes the importance of continuous innovation within the health sciences community to address the evolving needs of researchers and healthcare professionals.

For the first time, this collaborative presentation of the awards involves not only Karger Publishers and Molecular Connections as main sponsors but also introduces BMJ Group into the fold, enhancing the competition’s prestige and scope. The incorporation of BMJ Group signifies a noteworthy expansion of the award’s influence across the science communication field.

Last year’s distinguished jury panel is set to return with Dan Atar, Jignesh Bhate, Stephanie Dawson, Phill Jones, Hylke Koers, and Daniel Ebneter, joined by newcomers Anca Babor, Director at BMJ Group, and Kate Gardner, co-founder of scientifyRESEARCH and a previous runner-up of the award. Their collective expertise and insights are expected to greatly enrich the evaluation process of the submissions.

Speaking on her involvement, Anca Babor expressed enthusiasm about the potential impacts of the award. “The Vesalius Innovation Award presents an invaluable platform for fostering innovative solutions that substantially enhance our scientific and healthcare landscapes,” she stated. Babor highlighted BMJ Group’s commitment to leveraging such pioneering ideas to continue their legacy of excellence and adaptability in the ever-dynamic STM sector.

Echoing her sentiments, Daniel Ebneter of Karger Publishers remarked on the significance of innovation in their field, especially amid the ongoing challenges and demands faced by the health sciences publishing ecosystem. “Returning as co-presenters for this definitive 5th year emphasizes our integral belief in nurturing innovative solutions that will benefit researchers, healthcare professionals, and patients alike,” Ebneter explained.

This year’s competition is inviting early-stage startups specializing in the health sciences to submit their applications by the end of August 2024 through the award’s designated website. The initiative not only aims to recognize outstanding contributions to the field but also to facilitate the development of pioneering enterprises in scientific communication.

Subsequently, after careful review by the jury, the top five shortlisted startups will have the remarkable opportunity to present their concepts at the STM Week in London this December. This event promises not only to spotlight their innovative ideas but also affords them critical exposure within the scientific community and the broader industry audience.

Through such spirited collaboration and a renewed focus on the future, the Vesalius Innovation Award continues to champion the cause of advancing science and healthcare by recognizing and rewarding the best and brightest innovators in the field. The continuation of this award underscores a shared vision among all sponsors and partners to forge ahead in creating tangible improvements in how science positively impacts society.